Norges Bank
EVLO

Norges Bank’s Evelo Biosciences, Inc. Common Stock EVLO Stock Holding History

Norges Bank’s Portfolio EVLO Stock Details EVLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-14,712
Closed -$621K – 2147
2022
Q2 		$621K Hold
14,712
– – ﹤0.01% 1998
2022
Q1 		$997K Hold
14,712
– – ﹤0.01% 2053
2021
Q4 		$1.79M Hold
14,712
– – ﹤0.01% 2045
2021
Q3 		$2.07M Hold
14,712
– – ﹤0.01% 2044
2021
Q2 		$4.04M Hold
14,712
– – ﹤0.01% 1935
2021
Q1 		$3.15M Buy
+14,712
New +$4.07M ﹤0.01% 1960

Other funds holding EVLO

FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $22.6B AUM 40.24% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HP
Harbourvest Partners Boston, Massachusetts $170M AUM 34.45% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Norges Bank's EVLO Position: Q3 2022 in Review

Norges Bank sold out of Evelo Biosciences, Inc. Common Stock (EVLO) in Q3 2022, closing a stake of 14,712 shares — an estimated $621K sold.

Norges Bank first reported a position in EVLO in Q1 2021 and held it in 6 quarters. The position peaked at $4.04M in Q2 2021. 41 funds tracked by Wall St. Rank hold EVLO as of Q3 2022.

  • Norges Bank reported no remaining Evelo Biosciences, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Norges Bank sold 14,712 Evelo Biosciences, Inc. Common Stock shares in Q3 2022, an estimated $621K.
  • Norges Bank first reported a position in Evelo Biosciences, Inc. Common Stock in Q1 2021 and held it in 6 quarters.
  • Norges Bank's Evelo Biosciences, Inc. Common Stock position peaked at $4.04M in Q2 2021.
  • 41 funds tracked by Wall St. Rank held Evelo Biosciences, Inc. Common Stock as of Q3 2022.

Based on Norges Bank's 13F filing for Q3 2022, filed 14 Nov 2022.